An observational study of correlation of cardiac manifestations with severity of COPD.

Dr. Karan Chawla; Dr. Jayant K.  Golwalkar; Dr. Nisar  Shaikh; Dr. Pratap  Chavre

doi:10.46858/vimshsj.8404

Authors

Dr. Karan Chawla MMPPCT’s Ashwini Rural Medical College, Hospital & Research Center, Kumbhari, Solapur-413006, Maharashtra, India
Dr. Jayant K. Golwalkar
Dr. Nisar Shaikh
Dr. Pratap Chavre

DOI:

https://doi.org/10.46858/vimshsj.8404

Keywords:

Chronic Obstructive Pulmonary Disease (COPD), Cardiac manifestations, Pulmonary vascular disease

Abstract

Introduction: Various systemic manifestations and complications have been observed throughout the course of Chronic Obstructive Pulmonary Disease. Out of those manifestations one of the important manifestations is cardiac involvement. The major and well-known cardiac complications of COPD are pulmonary vascular disease and its impact on right ventricular function, higher incidence of myocardial infarction and arrhythmias. These complications correlate inversely with survival. Aim: To study cardiac manifestations in COPD patients and its correlation with severity of the disease. Methodology: This observational study was conducted in the department of medicine at a tertiary care hospital in Solapur, Maharashtra. Data of 80 patients diagnosed and their cardiac status assessed on the basis of clinical findings, radiological changes and spirometry, electrocardiography and echocardiography. All patients were analyzed for cardiac involvement based on symptomatology, ECG and 2D-ECHO results. Results: Out of 80 COPD patients 6 patients were GOLD class 1 (mild), 28 in class 2 (moderate), 36 in class 3 (severe) and 10 patients belonged to GOLD class 4 (very severe). Cardiovascular complications were found in 40 patients out of 80. Of these, pulmonary hypertension was found in 45%, IHD in 30%, cor-pulmonale in 20% and arrhythmias were found in 10% of which supraventricular arrhythmias were seen in 75% and ventricular arrhythmia in25%. Conclusion: Our study concluded that patients with mild to moderate COPD may also have cardiac complications. Due to common symptomatology, they are difficult to diagnose. Hence, it is necessary at the time of initial diagnosis to carry out ECG and 2DECHO for early detection and for better management of these patients.

Downloads

Download data is not yet available.

References

Alwan A. Global status report on non-communicable diseases 2010. World Health Organization; 2011.

Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, AlMazroa MA. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden -of Disease Study 2010. The lancet. 2012 Dec 15;380(9859):2095-128.

McKay AJ, Mahesh PA, Fordham JZ, Majeed A. Prevalence of COPD in India: a systematic review. Primary Care Respiratory Journal. 2012; 21 (3):313-21. DOI: https://doi.org/10.1016/S2214-109X(18)30409-1.

Salvi S, Kumar GA, Dhaliwal RS, Paulson K, Agrawal A, Koul PA, Mahesh PA, Nair S, Singh V, Aggarwal AN, Christopher DJ. The burden of chronic respiratory diseases and their heterogeneity across the states of India: the Global Burden of Disease Study 1990– 2016. The Lancet Global Health. 2018 Dec 1;6(12):e1363-74 DOI: https://doi.org/10.1016/S2214-109X(18)30409-1.

Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. Plos med. 2006Nov28;3(11):e442. DOI: https://doi.org/10.1371/ journal.pmed.0030442.

Morgan AD, Zakeri R, Quint JK. Defining the relationship between COPD and CVD: what are the implications for clinical practice? Therapeutic Advances in Respiratory Disease. 2018 Jan 19;12:1753465817750524. DOI: 10.1177/1753465817750524.

McAllister DA, Maclay JD, Mills NL, Leitch A, Reid P, Carruthers R, O’Connor J, McAlpine L, Chalmers G, Newby DE, Clark E. Diagnosis of myocardial infarction following hospitalisation for exacerbation of COPD. European Respiratory Journal. 2012 May 1 ; 3 9( 5 ): 1097-103 . DOI: 10.1183/09031936.00124811.

Falk JA, Kadiev S, Criner GJ, Scharf SM, Minai OA, Diaz P. Cardiac disease in chronic obstructive pulmonary disease. Proceedings of the American thoracic society. 2008; 5(4):543-8. DOI: 10.1513/pats.200708-142ET.

Terzano C, Romani S, Conti V, Paone G, Oriolo F, Vitarelli A. Atrial fibrillation in the acute, hypercapnic exacerbations of COPD. Eur Rev Med Pharmacol Sci. 2014 Oct 1;8(19):2908-17. DOI:https://doi.org/10.2147/COPD.S143691.

Chemla D, Castelain V, Humbert M, Hébert JL, Simonneau G, Lecarpentier Y, Hervé P. New formula for predicting mean pulmonary artery pressure using systolic pulmonary artery pressure. Chest. 2004 Oct 1; 126(4):1313-7. DOI: 10.1378/chest.126.4.1313.

Anderson JL, Adams CD, Antman EM, et al. 2011 ACCF/ AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [published correction appears in Circulation. 2011 Jun 7;123(22):e627]. Circulation. 2011;123(18):e426 e579. DOI: 10.1161/CIR. 0b013e318212bb8b.

Reddy S, Rajender RN. Prevalence of pulmonary hypertension in COPD patients: a retrospective observational study. Int J Integrative Med Sci. 2016;3(5):2859. DOI:10.16965/ijims.2016.119.

Gupta NK, Agrawal RK, Srivastav AB, Ved ML. Echocardiographic evaluation of heart in chronic obstructive pulmonary disease patient and its correlation with the severity of disease. Lung India: official organ of Indian Chest Society. 2011 Apr;28(2):105. DOI: 10.4103/0970-2113.80321.

Katiyar V, Khare RK. Prevalence of pulmonary hypertension in COPD. International Journal of Advances in Medicine. 2018 Mar; 5(2):356.DOI: http://dx.doi.org/10.18203/2349-3933.ijam20181061.

Dave L, Dwivedi P, Srivastava N, Yadav BS, Dohre R. A study of cardiovascular manifestations of COPD. Int J Res Health Sci. 2014 Jul 31; 2(3):812-7.

Kaushal M, Shah PS, Shah AD, Francis SA, Patel NV, Kothari KK. Chronic obstructive pulmonary disease and cardiac comorbidities: A cross-sectional study. Lung India: official organ of Indian Chest Society. 2016 Jul;33(4):404. DOI: 10.4103/0970-2113.184874.

Gupta AS, Rajesh V, James P. Cardiovascular comorbidities associated with patients with chronic obstructive pulmonary disease–a hospital-based study. Egyptian Journal of Bronchology. 2019 Dec1;13(5):591DOI: 10.4103/ejb.ejb_64_19.

Sushil S Anturlikar, Vaishali S Anturlikar, Dhaval K Patil.A clinical study of COPD with special reference to arrhythmia. MedPulse International Journal of Medicine. September 2019; 11(3): 175-179.DOI -https://doi.org/10.26611/10211136.

Dabadghao VS, Patil R, Sharma SK, Kakrani AL. A clinical study of cardiac rhythm disturbance in patients with chronic obstructive pulmonary disease using 24 hour Holter monitoring. International Journal of Research in Medical Sciences. 2016;4(3):1. DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20160491.